Norges Bank’s LB Pharmaceuticals LBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-20,000
Closed -$445K – 1789
2025
Q4
$445K Hold
20,000
– – ﹤0.01% 1554
2025
Q3
$316K Buy
+20,000
New +$317K ﹤0.01% 1496

Other funds holding LBRX

Norges Bank's LBRX Position: Q2 2026 in Review

Norges Bank sold out of LB Pharmaceuticals (LBRX) in Q2 2026, closing a stake of 20,000 shares — an estimated $445K sold.

Norges Bank first reported a position in LBRX in Q3 2025 and held it in 2 quarters. The position peaked at $445K in Q4 2025. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • Norges Bank reported no remaining LB Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Norges Bank sold 20,000 LB Pharmaceuticals shares in Q2 2026, an estimated $445K.
  • Norges Bank first reported a position in LB Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Norges Bank's LB Pharmaceuticals position peaked at $445K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.